Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,619,243
-$4,389,001 QoQ
Shares Held
106,029
+4.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#281
of 1,408 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ISTHMUS PARTNERS, LLC holds $12,442,248 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (61.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
106,029 | $7,619,243 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
43,474 | $4,823,005 |
All Filings in ZTS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,619,243 | 106,029 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $12,008,244 | 101,584 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $9,325,652 | 74,119 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $10,460,855 | 71,493 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,978,880 | 70,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,535,708 | 70,062 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $11,213,005 | 68,821 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,412,446 | 68,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,769,063 | 67,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,405,769 | 67,406 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $13,273,132 | 67,250 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,445,274 | 65,785 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,320,913 | 65,739 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $10,913,304 | 65,569 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||